Cargando…

Similarities and differences between multiple sclerosis and type 1 diabetes

Multiple sclerosis (MS) and type 1 diabetes (T1D) are chronic conditions that result from dysfunction of the immune system. Their common root in autoimmunity stimulates interest in the exploration of similarities and differences between the two diseases. Genetic susceptibility is relevant, creating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozzilli, Valeria, Grasso, Eleonora Agata, Tomassini, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285024/ https://www.ncbi.nlm.nih.gov/pubmed/34651395 http://dx.doi.org/10.1002/dmrr.3505

Ejemplares similares

Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)

Predicting the profile of increasing disability in multiple sclerosis
por: Tomassini, Valentina, et al.
Publicado: (2018)

Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
por: Avolio, Carlo, et al.
Publicado: (2021)

Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging
por: Mascali, Daniele, et al.
Publicado: (2023)

Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation
por: Chiarelli, Antonio Maria, et al.
Publicado: (2022)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Oral contraceptives combined with interferon β in multiple sclerosis
por: Pozzilli, Carlo, et al.
Publicado: (2015)

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
por: Nistri, Riccardo, et al.
Publicado: (2021)

Proposal for generating new beta cells in a muted immune environment for type 1 diabetes
por: Levetan, Claresa, et al.
Publicado: (2013)

A rare association between multiple sclerosis and Charcot‐Marie‐Tooth type 1B
por: Cortese, Rosa, et al.
Publicado: (2016)

Neuroplasticity and Motor Rehabilitation in Multiple Sclerosis
por: Lipp, Ilona, et al.
Publicado: (2015)

Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2013)

Paediatric transverse myelitis during COVID-19 asymptomatic infection: A case report
por: Grasso, Eleonora, et al.
Publicado: (2021)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
por: Sbardella, Emilia, et al.
Publicado: (2009)

Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis
por: De Giglio, L., et al.
Publicado: (2015)

Tractography in the presence of multiple sclerosis lesions
por: Lipp, Ilona, et al.
Publicado: (2020)

The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence
por: Tomassini, Valentina, et al.
Publicado: (2016)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Chewing the fat on an emerging target in multiple sclerosis
por: Lim, Chai K.
Publicado: (2021)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

An insight about genomic susceptibility & multiple sclerosis
por: Verma, Rajesh, et al.
Publicado: (2017)

European and American Guidelines for Multiple Sclerosis Treatment
por: Ghezzi, Angelo
Publicado: (2018)

Seeking neuroprotection in multiple sclerosis: an ongoing challenge
por: Antel, Jack P., et al.
Publicado: (2023)

Serum markers of multiple sclerosis - a new approach
por: Torkildsen, Øivind
Publicado: (2021)

Multiple sclerosis: major histocompatibility complexity and antigen presentation
por: Ramagopalan, Sreeram V, et al.
Publicado: (2009)

B cells and multiple sclerosis spinal cord pathology
por: Schmierer, Klaus, et al.
Publicado: (2020)

Monkeypox in Multiple Sclerosis patients: Should we be alert?
por: Boldrini, Vinícius Oliveira, et al.
Publicado: (2022)

The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review
por: Prosperini, Luca, et al.
Publicado: (2013)

Diagnosis and management of multiple sclerosis: MRI in clinical practice
por: Tomassini, Valentina, et al.
Publicado: (2020)

Medical congresses at the click of a mouse
por: Pozzilli, Paolo, et al.
Publicado: (2021)

A mechanism-based classification of pain in multiple sclerosis
por: Truini, A., et al.
Publicado: (2012)

Fungal microbiome and multiple sclerosis: The not-so-new kid on the block
por: Mangalam, Ashutosh K.
Publicado: (2021)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier
por: Yeandle, David, et al.
Publicado: (2018)

Honing in on magnetic resonance imaging predictors of multiple sclerosis pathology
por: Schmierer, Klaus
Publicado: (2023)

Similar Yet Different: The COVID-19 Pneumothorax
por: Mitzman, Brian
Publicado: (2022)

A multiple sclerosis patient-oriented multiomics analysis tells us where to go next: Commentary for: “Alterations of host-gut microbiome interactions in multiple sclerosis”
por: Yamamura, Takashi, et al.
Publicado: (2022)

Are there similarities between the Corona and the climate crisis?
por: Schmidt, Robert C.
Publicado: (2021)

Prediction of Type 1 Diabetes
por: Erlich, Henry A., et al.
Publicado: (2013)

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
por: Gasperini, Claudio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_348hiqag3ocstd6s8snr8492dk